Risk factor
Considerable default risk
Profitability factor
Greatly overvalued vs peers
About
Specializing in regenerative tissue medicine, L&C BIO Co., Ltd. operates as a dedicated research and development enterprise. The company's diverse product range encompasses human tissue products, various medical devices, and a selection of cosmetic solutions. Established in 2011, this firm is headquartered in Seongnam, South Korea.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EB
Target Price
The average target price of 290650.KQ is 90303 and suggests 2.62% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recomme